GeneHealth - Your precision medicine

Rosacea

Disease Details

Family Health Simplified

Buy Membership

Description: Rosacea is a chronic skin condition that primarily affects the face, causing redness, visible blood vessels, and sometimes pimples.
Type: Rosacea is a chronic inflammatory skin condition. The type of genetic transmission for rosacea is not clearly defined, as it is believed to be a complex disorder influenced by multiple genetic and environmental factors. It is not inherited in a simple Mendelian fashion, but there may be a hereditary component, as it can run in families.
Signs And Symptoms: Rosacea typically begins with reddening (flushing) of the skin in symmetrical patches near the center of the face. Common signs can depend on age and sex: flushing and red swollen patches are common in the young, small and visible dilated blood vessels in older individuals, and swelling of the nose is common in men. Other signs include lumps on the skin (papules or pustules) and swelling of the face. Many people experience stinging or burning pain and rarely itching.Skin problems tend to be aggravated by particular trigger factors, that differ for different people. Common triggers are ultraviolet light, heat, cold, or certain foods or beverages.
Prognosis: Rosacea is a chronic skin condition characterized by facial redness, pimples, swelling, and dilated blood vessels. The prognosis for rosacea varies among individuals. While there is no cure, symptoms can be managed effectively with a combination of medical treatments and lifestyle modifications. The condition tends to be lifelong but can go through cycles of flare-ups and remission. Early diagnosis and treatment can help control the symptoms and prevent progression. In some cases, long-term treatment may be necessary to keep the condition under control.
Onset: Rosacea typically has an onset between the ages of 30 and 50. It is more common in fair-skinned individuals and predominantly affects women, though men often experience more severe symptoms.
Prevalence: Rosacea is a common chronic skin condition. It affects approximately 5% to 10% of the population, primarily individuals between the ages of 30 and 50. It is more prevalent in people with fair skin, particularly those of Northern European descent.
Epidemiology: Rosaceae affects around 5% of people worldwide. Incidence varies by ethnicity, and is particularly prevalent in those with Celtic heritage. Men and women are equally likely to develop rosacea.
Intractability: Rosacea is a chronic skin condition that often requires long-term management. While there is no cure, effective treatments can help control and reduce symptoms. The intractability varies among individuals; some may achieve remission or significant symptom control, while others may experience persistent or recurrent symptoms despite treatment.
Disease Severity: Disease severity for rosacea can vary widely among individuals. It typically ranges from mild to severe and can progress if left untreated. In mild cases, individuals might experience occasional flushing and minor redness. Moderate cases can involve more persistent redness, visible blood vessels, and occasional pustules or papules. Severe rosacea may include substantial redness, numerous pustules, thickening of the skin, and even ocular involvement. It's crucial to seek medical advice to manage the condition effectively.
Healthcare Professionals: Disease Ontology ID - DOID:8881
Pathophysiology: **Pathophysiology of Rosacea:**

Rosacea is a chronic inflammatory skin condition with a complex pathophysiology that is not fully understood, involving genetic, environmental, vascular, and immune system factors. Key elements include:

1. **Vascular Dysregulation**: Rosacea is often characterized by frequent flushing and persistent erythema (redness), suggesting abnormal regulation of blood flow and increased reactivity of the blood vessels in the skin.

2. **Immune System Dysregulation**: Inflammatory mediators and an overactive innate immune response, including antimicrobial peptides such as cathelicidin and the activation of the kallikrein-kinin system, play significant roles in mediating inflammation.

3. **Microorganisms**: The skin microbiota, particularly Demodex mites and bacteria such as *Propionibacterium acnes*, have been implicated in triggering immune responses and inflammation.

4. **Genetic Predisposition**: There is evidence that individuals with rosacea may have a genetic predisposition to developing the condition, though no specific genes have been definitively identified.

5. **Environmental Triggers**: Various factors such as sun exposure, spicy foods, alcohol, stress, and temperature extremes can trigger or exacerbate rosacea symptoms by affecting the vascular and immune systems.

Understanding these components can help in managing the condition through targeted treatments and lifestyle modifications.
Carrier Status: Rosacea is a chronic skin condition characterized by facial redness, pimples, and sometimes thickened skin. There is no carrier status for rosacea as it is not a contagious or infectious disease.
Mechanism: Rosacea is a chronic skin condition primarily affecting the facial skin, characterized by redness, visible blood vessels, and sometimes acne-like pustules. While its exact cause isn't fully understood, several mechanisms and molecular pathways have been implicated:

### Mechanism
1. **Immune System Dysregulation**: An abnormal innate immune response leads to chronic inflammation. Overactivity of cathelicidins, antimicrobial peptides in the skin, contributes to this inflammatory response.

2. **Vascular Abnormalities**: Rosacea involves changes in the blood vessels, leading to persistent redness and visible capillaries. Factors such as sun damage can exacerbate these vascular changes.

3. **Microbial Factors**: Demodex mites, which naturally inhabit human skin, are often found in higher numbers on rosacea patients' skin. Their role is not fully clear but they can trigger or exacerbate inflammation.

### Molecular Mechanisms
1. **Cathelicidins and Proteases**: Overexpression of cathelicidins and their activating enzymes (e.g., serine proteases like kallikreins) has been observed in rosacea. These molecules can induce inflammation and alter immune responses.

2. **Toll-like Receptors (TLRs)**: Increased activation of TLRs, especially TLR2, can lead to heightened innate immune responses. TLR2 activation has been associated with increased expression of inflammatory mediators.

3. **Matrix Metalloproteinases (MMPs)**: These enzymes, which degrade extracellular matrix components, are often upregulated in rosacea, contributing to tissue damage and inflammation.

4. **Vascular Endothelial Growth Factor (VEGF)**: VEGF overexpression can lead to new blood vessel formation (angiogenesis) and permeability, contributing to the vascular symptoms of rosacea.

5. **Reactive Oxygen Species (ROS)**: Elevated levels of ROS in the skin can contribute to oxidative stress, damaging the skin and exacerbating inflammation.

6. **Inflammatory Cytokines**: Key cytokines like TNF-alpha, IL-1, IL-6, and IL-8 are elevated in rosacea, driving the inflammatory response.

Overall, rosacea involves a complex interplay of immune system dysregulation, vascular abnormalities, microbial factors, and molecular mechanisms that lead to chronic inflammation and characteristic skin symptoms.
Treatment: The type of rosacea a person has informs the choice of treatment. Mild cases are often not treated at all, or are simply covered up with normal cosmetics.
Therapy for the treatment of rosacea is not curative, and is best measured in terms of reduction in the amount of facial redness and inflammatory lesions, a decrease in the number, duration, and intensity of flares, and concomitant symptoms of itching, burning, and tenderness. The two primary modalities of rosacea treatment are topical and oral antibiotic agents. Laser therapy has also been classified as a form of treatment. While medications often produce a temporary remission of redness within a few weeks, the redness typically returns shortly after treatment is suspended. Long-term treatment, usually 1–2 years, may result in permanent control of the condition for some patients. Lifelong treatment is often necessary, although some cases resolve after a while and go into a permanent remission. Other cases, if left untreated, worsen over time. Some people have also reported better results after changing diet. This is not confirmed by medical studies, even though some studies relate the histamine production to outbreak of rosacea.
Compassionate Use Treatment: For rosacea, compassionate use treatment options and off-label or experimental treatments include the following:

1. **Ivermectin**: While primarily approved for other uses, off-label topical ivermectin has shown efficacy in treating the inflammatory lesions of rosacea.

2. **Tacrolimus and Pimecrolimus**: These topical immunomodulators, typically used for eczema, have been used off-label for some cases of rosacea with variable results.

3. **Oral Isotretinoin**: Commonly used in severe acne, isotretinoin may be an option for severe or refractory rosacea but requires careful monitoring due to significant potential side effects.

4. **Laser and Light Therapy**: Lasers and intense pulsed light (IPL) treatments are sometimes used for managing erythema and telangiectasia associated with rosacea.

5. **Nutritional Supplements**: Some experimental treatments involve supplements such as omega-3 fatty acids, though evidence supporting their effectiveness is still limited.

Always consult a healthcare professional before starting any off-label or experimental treatment.
Lifestyle Recommendations: To manage rosacea effectively, consider the following lifestyle recommendations:

1. **Identify and Avoid Triggers**: Common triggers include spicy foods, alcohol, hot beverages, extreme temperatures, sun exposure, stress, and certain cosmetics and skincare products. Keep a diary to identify your specific triggers.

2. **Use Sun Protection**: Wear a broad-spectrum sunscreen with an SPF of 30 or higher daily, and use wide-brimmed hats and sunglasses when outdoors.

3. **Gentle Skincare Routine**: Use mild, non-abrasive cleansers and avoid products containing alcohol, menthol, camphor, or other irritants. Moisturize regularly to protect the skin barrier.

4. **Stress Management**: Practice stress-reducing techniques such as yoga, meditation, or deep-breathing exercises.

5. **Dietary Adjustments**: Consider a balanced diet and avoid food and drink that can exacerbate symptoms, including spicy foods, hot drinks, and alcohol.

6. **Avoid Overheating**: Stay cool by avoiding hot showers and baths, and use fans or air conditioning in hot weather.

7. **Limit Physical Exertion**: Exercise in a cool environment and choose low-intensity workouts to avoid overheating.

8. **Quit Smoking**: Smoking can worsen rosacea symptoms. Seek help to quit if needed.

9. **Consult Healthcare Providers**: Regularly consult with dermatologists to manage the condition and adjust treatment plans as necessary.

By incorporating these lifestyle recommendations, individuals with rosacea can better manage their symptoms and reduce flare-ups.
Medication: Medications with good evidence include topical metronidazole, ivermectin and azelaic acid. Good evidence medications taken by mouth include brimonidine, and doxycycline and isotretinoin. Lesser evidence supports tetracycline by mouth. Isotretinoin and tetracycline antibiotics, which may be used in more severe cases of inflammatory rosacea, are absolutely contraindicated in women who are pregnant, may become pregnant or lactating as they are highly teratogenic (associated with birth defects). Contraception is required for women of child bearing age who are using these medications.Metronidazole is thought to act through anti-inflammatory mechanisms, while azelaic acid is thought to decrease cathelicidin production. Oral antibiotics of the tetracycline class such as doxycycline, minocycline, and oxytetracycline are also commonly used and thought to reduce papulopustular lesions through anti-inflammatory actions rather than through their antibacterial capabilities.Topical minocycline applied as a foam is a newer treatment option for rosacea that the FDA has approved. Minocycline shows a targeted approach for managing inflammatory lesions of rosacea while minimizing systemic side effects commonly associated with oral antibiotic use. It is available in foam formulation and is applied to the affected areas once daily. Minocycline belongs to the tetracycline family of antibiotics and exhibits antimicrobial properties and anti-inflammatory activity, similar to other members of this class, such as doxycycline. Topical minocycline reduces inflammatory lesions associated with rosacea; however, rare adverse events such as folliculitis have been reported.Topical metronidazole is a commonly used treatment for rosacea; it is available in various formulations such as creams, gels, or lotions and applied to clean, dry skin once or twice daily. Topical metronidazole has been shown to effectively reduce inflammatory lesions and perilesional erythema associated with rosacea by inhibiting both microbial growth and pro-inflammatory mediators generated by neutrophils. Benefits of topical metronidazole include its effectiveness in reducing symptoms, extensive clinical experience supporting its use, and generally good tolerability with minimal systemic side effects; still, some patients may experience mild local irritation upon initial use, and it may have limited impact on persistent facial redness (erythema).Topical azelaic acid is available in gel or cream formulations; it exerts its effects by reducing inflammation through its activity on the cathelicidin pathway, which is upregulated in rosacea-affected skin; it also reduces inflammatory lesions and improves overall symptoms of rosacea; it has been well-studied and shown to be effective in clinical trials; still, some patients may experience mild local irritation during the first few weeks of use.Using alpha-hydroxy acid peels may help relieve redness caused by irritation, and reduce papules and pustules associated with rosacea.Oral Beta-blockers are often used for those with flushing due to rosacea. These include nadolol, propanolol or carvedilol. The possible adverse reactions of the oral beta-blockers include low blood pressure, low heart rate or dizziness. The oral α-2 adrenergic receptor agonist clonidine can also be used for flushing symptoms. The flushing and blushing that typically accompany rosacea may also be treated with the topical application of alpha agonists such as brimonidine which has vasoconstrictor activity and achieves maximal symptom improvement 3-6 hours after application, other topicals used for flushing or erythema include oxymetazoline or xylometazoline.Topical ivermectin is a treatment option for rosacea that targets Demodex mites, which are associated with inflammation in the skin of patients with rosacea; the cream is applied once daily to clean, dry skin. Topical ivermectin has been shown to reduce Demodex mite density and improve cutaneous inflammatory markers in clinical studies; overall, it decreases Demodex mite density and improves the symptoms of inflammation associated with rosacea; however, some patients may experience transient burning or itching upon application. Topical ivermectin offers a targeted approach for managing rosacea by addressing the role of Demodex mites in the disease process. A review found that ivermectin was more effective than alternatives for treatment of papulopustular acne rosacea. An ivermectin cream has been approved by the FDA, as well as in Europe, for the treatment of inflammatory lesions of rosacea. The treatment is based upon the hypothesis that parasitic mites of the genus Demodex play a role in rosacea. In a clinical study, ivermectin reduced lesions by 83% over 4 months, as compared to 74% under a metronidazole standard therapy. Quassia amara extract at 4% demonstrated to have clinical efficacy for rosacea. When compared to metronidazole 0.75% as usual care in a randomized, double-blinded clinical trial, Quassia amara extract at 4% demonstrated earlier onset of action, including improvement in telangiectasia, flushing, and papules. Quassia amara showed a sustained reduction of symptoms at 42 days of treatment.Cyclosporin eye drops have been shown to reduce symptoms in those with ocular rosacea. Cyclosporin should not be used in those with an active ocular infection. Other options include topical metronidazole cream or topical fusidic acid applied to the eyelids, or oral doxycycline in more severe cases of ocular rosacea. If papules and pustules persist, then sometimes isotretinoin can be prescribed.Systemic doxycycline modified-release capsules are commonly used for the treatment of rosacea. The capsules are taken orally once daily, usually in a low dose, to achieve anti-inflammatory effects. Doxycycline acts by inhibiting inflammation and reducing the production of reactive oxygen species associated with rosacea symptoms. The benefits of systemic doxycycline include its effectiveness in reducing inflammatory lesions, improving erythema, and controlling symptoms related to ocular involvement in rosacea patients; it is also well-tolerated at lower doses compared to traditional higher-dose regimens used for other indications. However, potential cons include gastrointestinal side effects such as nausea or abdominal pain, photosensitivity reactions that require sun protection measures during treatment, and rare instances of antibiotic-associated diarrhea or bacterial resistance development with long-term use.Encapsulated benzoyl peroxide (E-BPO) cream, a newly FDA-approved topical agent for inflammatory lesions of rosacea, utilizes porous silica microcapsule technology to slow the absorption of benzoyl peroxide and diminish potential irritation.
Repurposable Drugs: Repurposable drugs for rosacea primarily address its inflammatory and vascular components. Some examples include:

1. **Tetracyclines** (e.g., doxycycline, minocycline) - initially antibiotics, they have anti-inflammatory properties that help reduce rosacea symptoms.
2. **Metronidazole** - originally used as an antibiotic and antiprotozoal, it is effective topically for reducing inflammation and redness in rosacea.
3. **Ivermectin** - an antiparasitic agent shown to reduce inflammatory lesions in rosacea when used topically.
4. **Brimonidine** - an alpha-agonist used in glaucoma treatment that can be applied topically to reduce facial redness through vasoconstriction.
5. **Isotretinoin** - used primarily for severe acne, it can be effective in refractory rosacea cases due to its anti-inflammatory and sebaceous gland suppression properties.

These repurposed drugs leverage their existing pharmacological effects to manage various symptoms associated with rosacea.
Metabolites: Rosacea is a chronic inflammatory skin condition with various metabolites implicated in its pathophysiology. Some metabolites involved include:

1. **Cathelicidin**: An antimicrobial peptide that can become overactive, leading to inflammation.
2. **Matrix Metalloproteinases (MMPs)**: These enzymes break down collagen and other proteins, contributing to skin damage and inflammation.
3. **Reactive Oxygen Species (ROS)**: These can cause oxidative stress and exacerbate inflammation.

Research on the role of nanoformulations in rosacea treatment is ongoing but promising. Nanotechnology can enhance the delivery and efficacy of therapeutic agents, potentially reducing side effects. Some areas of exploration include:

1. **Nanoemulsions**: Used to improve the solubility and penetration of active ingredients.
2. **Lipid-based nanoparticles**: Such as liposomes, for targeted delivery of anti-inflammatory and antimicrobial agents.
3. **Polymeric nanoparticles**: To provide controlled release and improved stability of medications.

In summary, both metabolic pathways and nanotechnology play significant roles in understanding and potentially treating rosacea more effectively.
Nutraceuticals: Nutraceuticals, which are products derived from food sources with extra health benefits, may potentially aid in managing rosacea symptoms. Examples include:

1. Omega-3 Fatty Acids: Found in fish oil and flaxseed, omega-3s have anti-inflammatory properties that might help reduce rosacea flare-ups.
2. Probiotics: Beneficial bacteria that support gut health, which may, in turn, improve skin conditions like rosacea.
3. Green Tea Extract: Contains anti-inflammatory and antioxidant properties that may help soothe rosacea-prone skin.
4. Niacinamide (Vitamin B3): Known for its anti-inflammatory effects, it can help reduce redness and improve the skin barrier.

Always consult with a healthcare provider before starting any new nutraceutical regimen, especially for managing chronic conditions like rosacea.
Peptides: Peptides can play a beneficial role in managing rosacea by promoting skin barrier repair, reducing inflammation, and enhancing skin hydration. These small chains of amino acids signal the skin to produce more collagen, which can help improve skin texture and resilience. Peptides like Palmitoyl Tetrapeptide-7 and Palmitoyl Oligopeptide are commonly used in skincare products formulated for rosacea to help soothe and strengthen the skin.